Immunoepidemiologic studies of strongyloides stercoralis and human t lymphotropic virus type i infections in jamaica

Journal of Infectious Diseases

Volumn 169, Issue 3, 1994, Pages 692-696

  Robinson, R D ^a,b   Lindo, J F ^a,b,c   Neva, F A ^a,b   Gam, A A ^a,b   Vogel, P ^a,b   Terry, S I ^a,b,c   Cooper, E S ^a,b  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c CAIRNS BASE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IMMUNOGLOBULIN E; VIRUS PROTEIN;

AGE; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOGLOBULIN BLOOD LEVEL; JAMAICA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

ADULT; ANIMALS; FEMALE; HTLV-I INFECTIONS; HUMANS; JAMAICA; MALE; PREVALENCE; STRONGYLOIDES STERCORALIS; STRONGYLOIDIASIS;

EID: 0028047357     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/169.3.692     Document Type: Article

References (15)

1. Genta RM. Strongyloidiasis. Baillieres Clin Trop Med Commun Dis 1987;2:645-65.
2. Nakada K, Kohakura M, Komoda H, Hinuma Y. High incidence of HTLV-I antibody in carriers of strongyloidiasis. Lancet 1984;1:633.
3. Fujita K, Tajima K, Tominaga S, et al. Seroepidemiological studies on Strongyloides infection in adult T-cell leukaemia virus carriers in Okinawa Island, Japan. Trop Med 1985;27:203-9.
4. Neva FA, Murphy EL, Gam AA, Hanchard B, Figueroa JP, Blattner WA. Antibodies to Strongyloides stercoralis in healthy Jamaican carriers of HTLV-I. N Engl J Med 1989;320:252.
5. Terry SI, Blattner WA, Neva FA, et al. Coincidental HTLV-I infection influences outcome of treatment of strongyloidiasis [abstract]. West Ind Med J 1989:38:035.
6. Popovic M, Flomenberg N, Volkman DJ, et al. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science 1984;226:459-62.
7. Matsumoto T, Miike T, Mizoguchi K, et al. Decreased serum levels of IgE and IgE-binding factors in individuals infected with HTLV-I. Clin Exp Immunol 1990;81:207-11.
8. Speed JC, Culpepper V, Thompson DE, Henson P, Wint B, Bundy DAP. A community-based study of gastrointestinal helminth and protozoan infection in western Jamaica. West Ind Med J 1987;36:73-9.
9. Neva FA. Biology and immunology of human strongyloidiasis. J Infect Dis 1986;153:397-406.
10. Murphy EL, Figueroa JP, Gibbs WN, et al. Human T-lymphotropic virus type-I (HTLV-I) seroprevalence in Jamaica: I. demographic determinants. Am J Epidemiol 1991; 113:1114-24.
11. Meddis R. Statistics using ranks. A unified approach. Oxford, UK: Blackwell, 1984.
12. Arakaki T, Asato R, Ikeshiro T, Iwanaga M. Is the prevalence of HTLV-I infection higher in Strongyloides carriers than in noncarriers? Trop Med Parasitol 1992;43:199-200.
13. Yamaguchi K, Matutes E, Catovski D, Galton DAG, Nakada K, Takat-suki K. Strongyloides stercoralis as a candidate co-factor for HTLV-I-induced leukemogenesis. Lancet 1987;2:94-5.
14. Nakada K, Yamaguchi K, Furugen S, et al. Monoclonal integration of HTLV-I proviral DNA in patients with strongyloidiasis. Int J Cancer 1987;40:145-8.
15. Newton RC, Limpuangthip P, Greenberg S, Gam A, Neva FA. Strongyloides stercoralis hyperinfection in a carrier of HTLV-1 with evidence of selective immunosuppression. Am J Med 1992;92:202-7.